Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2898480012 | Metformin hydrochloride + saxagliptin (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2901201016 | Metformin hydrochloride + saxagliptin | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Metformin hydrochloride + saxagliptin | Is a | Product containing saxagliptin (medicinal product) | false | Inferred relationship | Some | ||
| Metformin hydrochloride + saxagliptin | Is a | Product containing metformin hydrochloride | false | Inferred relationship | Some | ||
| Metformin hydrochloride + saxagliptin | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | ||
| Metformin hydrochloride + saxagliptin | Has active ingredient | Saxagliptin (substance) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet | Is a | False | Metformin hydrochloride + saxagliptin | Inferred relationship | Some | |
| Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet | Is a | False | Metformin hydrochloride + saxagliptin | Inferred relationship | Some | |
| Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | False | Metformin hydrochloride + saxagliptin | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR